Changgeng Peng investigates gene regulatory networks and sensory neuron circuits underlying pain. Integrating genetics, molecular biology, and pharmacology, the work identifies and validates druggable targets to modulate nociception and neuropathic pain, enabling non‑opioid therapeutic strategies.